Currently out of the existing stock ratings of Alex Arfaei, 64 are a BUY (54.24%), 38 are a HOLD (32.2%), 16 are a SELL (13.56%).

Alex Arfaei

Work Performance Price Targets & Ratings Chart

Analyst Alex Arfaei, carries an average stock price target met ratio of 86.81% that have a potential upside of 44.45% achieved within 621 days. Previously, Alex Arfaei worked at BMO.

Alex Arfaei’s has documented 236 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ZTS, Zoetis at 09-May-2019.

Wall Street Analyst Alex Arfaei

Analyst best performing recommendations are on KIN (KINDRED BIOSCIENCES).
The best stock recommendation documented was for KIN (KINDRED BIOSCIENCES) at 11/15/2015. The price target of $5 was fulfilled within 1 day with a profit of $0.47 (8.59%) receiving and performance score of 85.92.

Average potential price target upside

of $23.19 (42.58%) on ABBV (ABBVIE).
of $23.01 (52.86%) on MRK (MERCK MPANY).
of $16.94 (35.48%) on BMY (BRISTOL-MYERS SQUIBB COMPANY).

ABBV AbbVie BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer AZN AstraZeneca PLC ADR KIN Kindred Biosciences ZTS Zoetis

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Gary Nachman (RAYMOND JAMES)